D75.81
Billable codeMyelofibrosis
The ICD-10 code for myelofibrosis is D75.81.
Clinical notes
Code first
This code represents a manifestation of an underlying disease. Coding convention requires the underlying (etiology) code to be sequenced first, with this code listed second.
- the underlying disorder, such as:
- malignant neoplasm of breast (C50.-)
Excludes1 (not coded here)
An Excludes1 note is a pure exclusion: the excluded condition and this code should never be reported together, because the two conditions cannot occur at the same time (e.g. a congenital form vs. an acquired form of the same disease).
Also known as
Alternate wording, synonyms, or specific conditions that fall under this code, listed to help confirm you've picked the right one.
- Myelofibrosis NOS
- Secondary myelofibrosis NOS
Use additional code
This code represents an underlying condition. When a related manifestation is also present, coding convention calls for an additional code to be listed after this one.
- [object Object]
- [object Object]
Documentation support
General coding-documentation guidance — not a substitute for payer-specific requirements or professional coding judgment.
- •Confirm the excluded condition(s) listed above are not also present — Excludes1 conditions cannot be coded together with this one.
- •This code represents a manifestation. Documentation should identify the underlying condition, which must be coded first.
- •If the associated manifestation or related condition noted above is also documented, an additional code should be reported alongside this one.
- •As a general rule, code to the highest level of specificity supported by the documentation in the medical record.
ICD-9-CM equivalent
Informational only — GEM mappings are approximate, not guaranteed one-to-one equivalents. Verify before use in billing.
- 28983
Associated MS-DRGs
D75.81 can serve as the principal diagnosis for these Medicare Severity Diagnosis-Related Groups.
Informational only — actual DRG assignment also depends on procedures, complications/comorbidities (CC/MCC), discharge status, and payer-specific rules not reflected here.
- DRG 814Reticuloendothelial and Immunity Disorders with MCC
- DRG 815Reticuloendothelial and Immunity Disorders with CC
- DRG 816Reticuloendothelial and Immunity Disorders without CC/MCC
- DRG 820Lymphoma and Leukemia with Major O.R. Procedures with MCC
- DRG 821Lymphoma and Leukemia with Major O.R. Procedures with CC
- DRG 822Lymphoma and Leukemia with Major O.R. Procedures without CC/MCC
- DRG 823Lymphoma and Non-Acute Leukemia with Other Procedures with MCC
- DRG 824Lymphoma and Non-Acute Leukemia with Other Procedures with CC
- DRG 825Lymphoma and Non-Acute Leukemia with Other Procedures without CC/MCC
- DRG 840Lymphoma and Non-Acute Leukemia with MCC
- DRG 841Lymphoma and Non-Acute Leukemia with CC
- DRG 842Lymphoma and Non-Acute Leukemia without CC/MCC